MoneyWorks4Me

Dr.Reddy's Laboratories informs about press release

19 Dec 2022 Evaluate
Dr.Reddy's Laboratories has informed that it enclosed Press Release titled 'Dr. Reddy's successfully completes Phase 1 study of DRL_TC, a proposed biosimilar of tocilizumab’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1840.65
Dr. Reddys Labs. 1145.35
Cipla 1352.00
Lupin 2053.35
Zydus Lifesciences 1100.10
View more..